rs4648049
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003998.4(NFKB1):c.1210+12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0467 in 1,603,918 control chromosomes in the GnomAD database, including 2,046 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.065 ( 406 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1640 hom. )
Consequence
NFKB1
NM_003998.4 intron
NM_003998.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.05
Publications
6 publications found
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
- immunodeficiency, common variable, 12Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- common variable immunodeficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 4-102593580-C-T is Benign according to our data. Variant chr4-102593580-C-T is described in ClinVar as Benign. ClinVar VariationId is 1168687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0651 AC: 9902AN: 152052Hom.: 401 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9902
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0462 AC: 11217AN: 243016 AF XY: 0.0447 show subpopulations
GnomAD2 exomes
AF:
AC:
11217
AN:
243016
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0448 AC: 65026AN: 1451748Hom.: 1640 Cov.: 34 AF XY: 0.0443 AC XY: 31985AN XY: 722378 show subpopulations
GnomAD4 exome
AF:
AC:
65026
AN:
1451748
Hom.:
Cov.:
34
AF XY:
AC XY:
31985
AN XY:
722378
show subpopulations
African (AFR)
AF:
AC:
3999
AN:
32628
American (AMR)
AF:
AC:
908
AN:
42892
Ashkenazi Jewish (ASJ)
AF:
AC:
293
AN:
25720
East Asian (EAS)
AF:
AC:
2045
AN:
39536
South Asian (SAS)
AF:
AC:
2374
AN:
84872
European-Finnish (FIN)
AF:
AC:
3286
AN:
53164
Middle Eastern (MID)
AF:
AC:
146
AN:
5660
European-Non Finnish (NFE)
AF:
AC:
49222
AN:
1107452
Other (OTH)
AF:
AC:
2753
AN:
59824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2630
5260
7891
10521
13151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1864
3728
5592
7456
9320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0653 AC: 9940AN: 152170Hom.: 406 Cov.: 32 AF XY: 0.0657 AC XY: 4887AN XY: 74402 show subpopulations
GnomAD4 genome
AF:
AC:
9940
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
4887
AN XY:
74402
show subpopulations
African (AFR)
AF:
AC:
4948
AN:
41496
American (AMR)
AF:
AC:
569
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
41
AN:
3472
East Asian (EAS)
AF:
AC:
259
AN:
5184
South Asian (SAS)
AF:
AC:
167
AN:
4824
European-Finnish (FIN)
AF:
AC:
692
AN:
10586
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3083
AN:
68010
Other (OTH)
AF:
AC:
108
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
463
925
1388
1850
2313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
186
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.